
Pharma Pulse 6/7/24: How Much Does a Day of Delay Really Cost? BranchLab Launches Privacy-Safe Healthcare Advertising Solution & more
The latest news for pharma industry insiders.
New research updates estimated value of lost time.
A new study published April 2024 in the JAMA Network looked to establish a link between burn pits and higher respiratory and cardiovascular disease in veterans, responding to widespread concern from veterans.
Sites can encounter a wide range of challenges when operationalizing study protocols, including the need to manage frequent and lengthy patients visits, coordinate complicated procedure schedules and utilize multiple disparate technology systems. Applied analytics enable data-driven protocol design that can help sponsors mitigate these trial challenges.
Data collected from sites can help uncover specific protocol elements that drive sites’ perception of burden. These findings can be used to optimize protocol design to decrease burden and improve site experience, potentially leading to positive outcomes such as facilitating the collection of cleaner data and improving protocol compliance.
BNN Breaking had millions of readers, an international team of journalists and a publishing deal with Microsoft. But it was full of error-ridden content.
Amid increased state and industry regulations, BranchLab provides a new solution for healthcare and pharma brands to reach consumers in a privacy-compliant way
That’s a wrap!! What an amazing week at the 2024 BIO International Convention in San Diego!! We recorded some great interviews with MJH’s very own
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

